Recurrent cyclin D2 mutations in myeloid neoplasms.
作者信息
Khanna V, Eide C A, Tognon C E, Maxson J E, Wilmot B, Bottomly D, McWeeney S, Edwards V D K, Druker B J, Tyner J W
机构信息
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Howard Hughes Medical Research Fellows Program, Howard Hughes Medical Institute, Portland, OR, USA.
出版信息
Leukemia. 2017 Sep;31(9):2005-2008. doi: 10.1038/leu.2017.195. Epub 2017 Jun 20.
Abstract
摘要
相似文献
1
Recurrent cyclin D2 mutations in myeloid neoplasms.髓系肿瘤中反复出现的细胞周期蛋白D2突变
Leukemia. 2017 Sep;31(9):2005-2008. doi: 10.1038/leu.2017.195. Epub 2017 Jun 20.
2
Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2.丙戊酸通过重新表达细胞周期蛋白 D2 来抑制癌细胞的增殖。
Carcinogenesis. 2013 May;34(5):1115-24. doi: 10.1093/carcin/bgt019. Epub 2013 Jan 24.
3
Novel role for the intraflagellar transport protein CMG-1 in regulating the transcription of cyclin-D2, E-cadherin and integrin-alpha family genes in mouse spermatocyte-derived cells.内鞭毛运输蛋白 CMG-1 在调节小鼠精母细胞衍生细胞中环细胞蛋白 D2、E-钙粘蛋白和整合素-α家族基因转录中的新作用。
Genes Cells. 2010 Jun;15(7):699-710. doi: 10.1111/j.1365-2443.2010.01414.x. Epub 2010 Jun 2.
4
Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.髓系肿瘤中复发性体细胞突变的诊断、预后及预测效用
Clin Lymphoma Myeloma Leuk. 2017 Jul;17S:S62-S74. doi: 10.1016/j.clml.2017.02.015.
5
Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.伴有孤立性17号染色体长臂等臂染色体的髓系肿瘤在SETBP1、SRSF2、ASXL1和NRAS中显示出高频突变。
Oncotarget. 2016 Mar 22;7(12):14251-8. doi: 10.18632/oncotarget.7350.
6
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.骨髓增殖性肿瘤和骨髓增生异常/骨髓增殖性肿瘤中钙网蛋白的体细胞突变。
Haematologica. 2014 Nov;99(11):1650-2. doi: 10.3324/haematol.2014.113944.
7
Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms.W515位点的17种突变导致MPL/血小板生成素受体的致癌激活：对骨髓增殖性肿瘤的影响
Leukemia. 2016 May;30(5):1214-6. doi: 10.1038/leu.2015.271. Epub 2015 Oct 6.
8
The role of ras gene mutations in myeloproliferative disorders.ras基因突变在骨髓增殖性疾病中的作用。
Clin Lab Med. 1990 Dec;10(4):797-807.
9
The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms.血液系统疾病中JAK2突变与易位的研究历程：发病机制、诊断与治疗前景，以及世界卫生组织对骨髓增殖性肿瘤的修订诊断标准
Hum Pathol. 2008 Jun;39(6):795-810. doi: 10.1016/j.humpath.2008.02.004.
10
[New mutations in myeloproliferative neoplasms; 2014 update].[骨髓增殖性肿瘤中的新突变；2014年更新]
Rinsho Ketsueki. 2014 Oct;55(10):1833-40.
引用本文的文献
1
Atypical CML: diagnosis and treatment.非典型慢性髓性白血病：诊断与治疗。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):476-482. doi: 10.1182/hematology.2023000448.
2
t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming.t(8;21)急性髓系白血病作为在基因调控和染色质编程水平上理解白血病发生机制的范例
Cells. 2020 Dec 13;9(12):2681. doi: 10.3390/cells9122681.
3
The RUNX1/RUNX1T1 network: translating insights into therapeutic options.RUNX1/RUNX1T1 网络：将见解转化为治疗选择。
Exp Hematol. 2021 Feb;94:1-10. doi: 10.1016/j.exphem.2020.11.005. Epub 2020 Nov 17.
4
CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients.CCND2突变在BCR-ABL1阴性骨髓增殖性肿瘤患者中是罕见事件。
Haematologica. 2021 Mar 1;106(3):863-864. doi: 10.3324/haematol.2020.252643.
5
The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.致癌转录因子 RUNX1/ETO 通过破坏细胞周期调控驱动白血病转化。
Cancer Cell. 2018 Oct 8;34(4):626-642.e8. doi: 10.1016/j.ccell.2018.08.015.
6
The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p.长链非编码 RNA SNHG1 通过与 EZH2 和 miR-154-5p 的相互作用调节结直肠癌细胞生长。
Mol Cancer. 2018 Sep 28;17(1):141. doi: 10.1186/s12943-018-0894-x.
7
Structural insights into the functional diversity of the CDK-cyclin family.结构洞察细胞周期蛋白依赖性激酶-细胞周期蛋白家族的功能多样性。
Open Biol. 2018 Sep;8(9). doi: 10.1098/rsob.180112.
本文引用的文献
1
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.在患有t(8;21)(q22;q22)急性髓系白血病的成年患者中，CCND1和CCND2基因的突变是常见事件。
Leukemia. 2017 Jun;31(6):1278-1285. doi: 10.1038/leu.2016.332. Epub 2016 Nov 15.
2
The genomic landscape of core-binding factor acute myeloid leukemias.核心结合因子急性髓系白血病的基因组格局
Nat Genet. 2016 Dec;48(12):1551-1556. doi: 10.1038/ng.3709. Epub 2016 Oct 31.
3
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.非典型慢性髓性白血病中反复出现的 ETNK1 突变。
Blood. 2015 Jan 15;125(3):499-503. doi: 10.1182/blood-2014-06-579466. Epub 2014 Oct 24.
4
Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy.无法分类的骨髓增生异常/骨髓增殖性肿瘤（MDS/MPN，U）：按治疗策略划分的自然史和临床结局
Leukemia. 2014 Apr;28(4):958-61. doi: 10.1038/leu.2014.8. Epub 2014 Jan 10.
5
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.致癌性 CSF3R 突变在慢性中性粒细胞白血病和非典型 CML 中的作用。
N Engl J Med. 2013 May 9;368(19):1781-90. doi: 10.1056/NEJMoa1214514.
6
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.CSF3R T618I 是慢性中性粒细胞白血病中一种高度普遍且特异性的突变。
Leukemia. 2013 Sep;27(9):1870-3. doi: 10.1038/leu.2013.122. Epub 2013 Apr 22.
7
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.非典型慢性髓性白血病中反复出现的 SETBP1 突变。
Nat Genet. 2013 Jan;45(1):18-24. doi: 10.1038/ng.2495. Epub 2012 Dec 9.
8
Cyclin D2 protein stability is regulated in pancreatic beta-cells.细胞周期蛋白D2的蛋白质稳定性在胰腺β细胞中受到调控。
Mol Endocrinol. 2009 Nov;23(11):1865-75. doi: 10.1210/me.2009-0057. Epub 2009 Jul 23.
9
Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication.细胞周期蛋白D1在S期的核内积累抑制了Cul4依赖的Cdt1蛋白水解，并触发了p53依赖的DNA再复制。
Genes Dev. 2007 Nov 15;21(22):2908-22. doi: 10.1101/gad.1586007.
10
Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias.在T细胞急性淋巴细胞白血病中，细胞周期蛋白D2因染色体易位至TCR基因座而失调。
Leukemia. 2006 Jan;20(1):82-6. doi: 10.1038/sj.leu.2404008.
Zotero 插件